• 검색 결과가 없습니다.

A Case of Gabapentin-induced Myoclonus in a Type 2 Diabetic Patient with End-stage Renal Disease

N/A
N/A
Protected

Academic year: 2022

Share "A Case of Gabapentin-induced Myoclonus in a Type 2 Diabetic Patient with End-stage Renal Disease "

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

S-348

A Case of Gabapentin-induced Myoclonus in a Type 2 Diabetic Patient with End-stage Renal Disease

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

*Eun Yeong Choe, Byung-Wan Lee

Development of myoclonus can be manifestated as a side effect of antiepileptic drugs in subjects with preexisting epilepsy, post-traumatic brain injury, encephalopathy, and focal and multifocal brain lesions. A 69-year-old male showed newly onset severe myoclonus and confusion 2 days after taking 1200 mg of gabapentin. He had end-stage renal disease secondary to type 2 diabetes and was on hemodialysis twice a week. After increasing hemodialyis 3 times a week and discontinuing gabapentin, myoclonus spontaneously resolved. Here we first report a case of myoclonus in a Korean subject with diabetic renal failure. We recommend that administration of gabapentin for diabetic subjects with renal disease should be cautious.

참조

관련 문서

OBJECTIVE—To determine whether early anatomical injury patterns in MRI correlate with the development of post-neonatal epilepsy in infants treated with selective head

AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects. Sanaka T, Akizawa T, Koide

four case reports and review of literature. Agranulocytosis associated with anti- thyroid drugs. Effects of patient age and drug dose. Remission in children with

defects, congenital hypothyroidism and severe global re- tardation 1). Fryns and Moerman reported a case of second male patient with a similar pattern of malformations

Recently, a urate anion exchanger that regulates blood uric acid levels was identified in the human kidney (hURAT1) by Enomoto et al 11, 12). A defect in the SLC22A12

–The AABB suggests adhering to a restrictive strategy in hospitalized patients with preexisting cardiovascular disease and considering transfusion for patients with symptoms or

A case of patient with multiple myeloma presenting as ascites, pleural and pericardial

In this study, we report a case of combined rare complications; rhabdomyolysis with an acute renal injury, pericardial effusion, and sudden hearing loss,